{{Rsnum
|rsid=10836347
|Gene=CD44
|Chromosome=11
|position=35231586
|Orientation=plus
|GMAF=0.112
|Gene_s=CD44
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 74.3 | 22.1 | 3.5
| HCB | 86.9 | 13.1 | 0.0
| JPT | 75.0 | 24.1 | 0.9
| YRI | 97.3 | 2.7 | 0.0
| ASW | 94.7 | 5.3 | 0.0
| CHB | 86.9 | 13.1 | 0.0
| CHD | 87.2 | 12.8 | 0.0
| GIH | 92.1 | 7.9 | 0.0
| LWK | 79.8 | 19.3 | 0.9
| MEX | 66.7 | 24.6 | 8.8
| MKK | 79.5 | 19.2 | 1.3
| TSI | 80.4 | 18.6 | 1.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22788972
|Title=CD44 rs13347 C&gt;T polymorphism predicts breast cancer risk and prognosis in Chinese populations
|OA=1
}}

{{PMID Auto
|PMID=23883608
|Title=Polymorphisms of CD44 gene and nasopharyngeal carcinoma susceptibility in a Chinese population
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}